Reduced FOXO3 levels in colorectal cancer [42], esophageal squamous cell carcinoma (ESCC) [43] and pancreatic ductal adenocarcinoma samples [44] also correlated with more advanced disease. Here, FOXO3 is linked to pancreatic ductal adenocarcinoma.